Oncogene-targeted antisense oligonucleotides for the treatment of Ewing sarcoma

By Maksimenko Andrei   Malvy Claude  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 825-830

Informa Healthcare

Access to resources Recommend Favorite

Emerging chemotherapeutic strategies for Huntington’s disease

By Ryu Hoon   Ferrante Robert J  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 2, 2005-05 ,pp. : 345-363

Informa Healthcare

Access to resources Recommend Favorite

Role of Genomics-Based Strategies in Overcoming Chemotherapeutic Resistance

By  

Current Pharmaceutical Biotechnology, Vol. 5, Iss. 5, 2004-10 ,pp. : 471-480

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

By DuBois Steven G.   Krailo Mark D.   Gebhardt Mark C.   Donaldson Sarah S.   Marcus Karen J.   Dormans John   Shamberger Robert C.   Sailer Scott   Nicholas Richard W.   Healey John H.   Tarbell Nancy J.   Randall R. Lor   Devidas Meenakshi   Meyer James S.   Granowetter Linda   Womer Richard B.   Bernstein Mark   Marina Neyssa   Grier Holcombe E.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 467-475

Blackwell Publishing

Access to resources Recommend Favorite

Emerging strategies for treatment of venous thromboembolism

By Prandoni Paolo  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 87-94

Informa Healthcare

Access to resources Recommend Favorite